New Delhi, February 1, 2025: In a significant announcement during the presentation of the Union Budget 2025, Finance Minister Nirmala Sitharaman declared that life-saving medicines will be exempted from customs duty. This decision is aimed at making critical healthcare treatments more accessible and affordable for patients across the country, particularly those battling severe and chronic illnesses.
The exemption applies to medicines used for the treatment of conditions such as rare diseases, cancer, and organ transplantation. The move is expected to reduce the financial burden on patients and families, supporting the government’s larger commitment to improving healthcare infrastructure and affordability. The announcement has been widely welcomed by healthcare experts and patient advocacy groups alike.
